Skip to content

Net Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$92.53M+37.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$166.56M+1.8%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-$94.39M-28.9%
Royalty Pharma logo
Royalty PharmaRPRX
$294.69M+23.1%
AbbVie logo
AbbVieABBV
$695M-46.0%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's net income?
Arrowhead Research (ARWR) reported net income of -$132.73M in Q1 2026.
How has Arrowhead Research's net income changed year-over-year?
Arrowhead Research's net income decreased by 135.8% year-over-year, from $370.45M to -$132.73M.
What is the long-term trend for Arrowhead Research's net income?
Over 4 years (2021 to 2025), Arrowhead Research's net income has grown at a -67.2% compound annual growth rate (CAGR), from -$140.85M to -$1.63M.
What does net income mean?
The total profit or loss remaining after all expenses and taxes are subtracted from total revenue.
How do you interpret net income?
An increase indicates improved profitability or reduced costs, while a decrease suggests declining margins or higher operational spending.
How does net income compare across companies?
Varies significantly in biotech based on clinical trial stages and partnership milestones; often negative for early-stage firms.